The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
NCT00076076
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
822
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Roflumilast
Sponsor
AstraZeneca